Arruda, L. C. et al. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone marrow transplantation 50, 380-389, doi:10.1038/bmt.2014.277 (2015).

Biaggio, R. T., Abreu-Neto, M. S., Covas, D. T. & Swiech, K. Serum-free suspension culturing of human cells: adaptation, growth, and cryopreservation. Bioprocess and biosystems engineering, doi:10.1007/s00449-015-1392-9 (2015).

Burt, R. K. et al. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. Jama 313, 275-284, doi:10.1001/jama.2014.17986 (2015).

de Paula, A. S. A. et al. Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis. Clinical science 128, 111-120, doi:10.1042/CS20140095 (2015).

Huuskes, B. M. et al. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy. FASEB J 29, 540-553, doi:10.1096/fj.14-254789 (2015).

Slavov, S. N. et al. Human parvovirus 4 in Brazilian patients with haemophilia, beta-thalassaemia major and volunteer blood donors. Haemophilia : the official journal of the World Federation of Hemophilia 21, e86-88, doi:10.1111/hae.12564 (2015).